medigraphic.com
Academia Mexicana de Neurología, A.C.

2007, Number 2

<< Back Next >>

Rev Mex Neuroci 2007; 8 (2)

“Energizing” drinks, social education and health

Souza MM, Cruz ML

Language: Spanish
References: 148
Page: 189-204
PDF size: 105.32 Kb.


ABSTRACT

Introduction: The present paper is a thematic revision which describes the main characteristics of the “energizing” drinks (ED) and their commercialization, under the premise of understanding the risks that their consumption entails, especially when the amount is not restricted, it is consumed by people affected in their health or they are mixed with legal or illegal drugs, which bases the debate with respect to their utility. Objective: The effects of the multiple ingredients contained in the ED, based on documented opinions are described. Also, recommendations are submitted to limit their consumption combined with toxic substances in youngsters or young adults. The context of their consumption and the prevailing confusion are clarified, being basis of the lucrative purpose of their production, starting from the false help to the physical restoration and general well-being that without scientific endorsement, supposedly they provide. Conclusion: The recognition of the deliberation of its producers is emphasized, which promotes confusion with hydrating drinks, of deserved marketing niche, and effective repairing intention of sportsmen’s health. The participation of the advertising tricks and their respective cheating intentions to sell, which affect the education and collective health is deplored. The revision culminates submitting recommendations addressed to be aware of the phenomenon in its readers, as well as the adequate promotion of education for health in personnel who work in those areas or other ones connected with the community well-being.


REFERENCES

  1. www.t1msn.com.mx/Salud/ciencia/art004salciebebidas/ Default.asp

  2. Kuriyama K, Hashimoto T. Interrelationship between taurine and GABA. Adv Exp Med Biol 1998; 442: 329-37.

  3. Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, Rhodes SL, Jungvig L, Gagne J. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA 2003; 289(12): 1537-45.

  4. Blokland A. Acetylcholine: a neurotransmitter for learning and memory? Brain Res Rev 1996; 21: 285-300.

  5. Rusted JM, Warburton DM. Molecules for modeling cognitive impairment. In: Hindmarch I; Hippius H, Wilcox G (Eds.). Dementia, molecules, methods and measurement. London: Academic; 1991.

  6. Eaton-Williams P, Warburton DM. A comparison of the effects of scopolamine and diazepam on working memory. Psychopharmacology 1991; 105: 442-5.

  7. Scholey AB. Fuel for thought. Psychologist 2001; 14: 196- 201.

  8. Scholey AB, Fowles K. Retrograde enhancement of kinaesthetic memory by alcohol and by glucose. Neurobiol Learn Mem 2002; 78: 477-83.

  9. Smith AP, Clark R, Gallagher J. Breakfast cereal and caffeinated coffee: effects on working memory, attention, mood & cardiovascular function. Physiol Behav 1999; 67: 9-17.

  10. Smith A, Brice C, Nash J, Rich N, Nutt DJ. Caffeine and central noradrenaline: effects on mood, cognitive performance, eye movements and cardiovascular function. J Psychopharmacol 2003; 17: 283-92.

  11. Sünram-Lea SI, Foster JK, Durlach P, Perez C. Investigation into the significance of task difficulty and divided allocation of resources on the glucose memory facilitation effect. Psychopharmacology 2002; 160: 387-97.

  12. Scholey AB, Harper S, Kennedy DO. Cognitive demand and blood glucose. Physiol Behav 2001; 73: 585-92.

  13. Ferreira SE, De Mello MT, Oliveira de Souza MLO. Efeit o das bebid as Alcoólicas pode ser afetado pela combinação com Bebidas Energéticas? Um estudo com usuários. Rev Assoc Med Bras 2004; 50(1): 48-51.

  14. Jain AC, Mehta MC, Billie M. Combined effects of caffeine and alcohol on hemodynamics and coronary artery blood flow in dogs. J Cardiovasc Pharmacol 1999; 33(1): 49-55.

  15. Biaggoni I, Paul S, Puckett A, Arzubiaga C. Caffeine and theophylline as adenosine receptor antagonists in humans. J Pharmacol Exp Ther 1991; 258: 588-93.

  16. Nehlig A, Daval J, Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Rev 1992; 17: 139-70.

  17. Pincomb GA, Wilson MF, Sung BH, Passey RB, Lovallo WR. Effects of caffeine on pressor regulation during rest and exercise in men at risk of hypertension. Am Heart J 1991; 122: 1107-25.

  18. Quinlan PT, Lane J, Aspinall L. Effects of hot tea, coffee and water ingestion on physiological responses and mood: the role of caffeine, water and beverage type. Psychopharmacology 1997; 134: 164-73.

  19. Quinlan PT, Lane J, Moore KL, Aspen J, Rycroft JA, O’Brien DC. The acute physiological effects of tea and coffee; the role of caffeine level. Pharmacol Biochem Behav 2000; 66: 19-28.

  20. Murray R. Energy drinks: Risk versus benefits. www.gsssiweb.com, 2006.

  21. American Psychiatric Association, APA. Diagnostical and Statiscal Manual of Mental Disorders DSM-IV-TR, 4a. Ed. Washington; 2001.

  22. Organización Mundial de la Salud, OMS. Décima Revisión Internacional de la Clasificación de Enfermedades. Capítulo V. Desórdenes mentales, conductuales y del desarrollo. OMS, Ginebra, 1993.

  23. Koelega HS. Effects of caffeine, nicotine and alcohol on vigilance performance. In: Snel J, Lorist M (Eds.). Nicotine, caffeine and social drinking. Amsterdam: OPA; 1998, p. 363-73.

  24. Souza y MM. Diagnóstico y Tratamiento de los Síndromes Adictivos. México: Editorial Ciencia y Cultura Latinoamérica; 2000.

  25. Cuisinier C. Changes in plasma and urinary taurine and amino acids in runners immediately and 24h after a marathon. Amino Acids 2001; 20(1): 13-23.

  26. Alford C, Cox H, Wescott R. The effects of red bull energy drink on human performance and mood. C-Amino Acids 2001; 21(2): 139-50.

  27. Seidl R, Peyrl A, Nicham R, Hauser E. A taurine and caffeinecontaining drink stimulates cognitive performance and well-being Part I. Amino Acids 2000; 19(3-4): 635-42.

  28. Bucci LR. Selected herbals and human exercise performance. Am J Clin Nutr 2000; 72(Suppl.): 624S-36S.

  29. Reid M, Hammersley R. Effects of carbohydrate intake on subsequent food intake and mood state. Physiol Behav 1995; 58: 421-7.

  30. American College of Sports Medicine, ACSM. American Dietetic Association, ADA. Dietitians of Canada, DC. Nutrition and athletic performance. Med Sci Sports Exerc 2000; 32(12): 2130-45.

  31. Magkos F, Kavouras SA. Caffeine and ephedrine: physiological, metabolic and performance-enhancing effects. Sports Med 2004; 34(13): 871-89.

  32. Charness ME, Simon RP, Greenberg. Ethanol and the Nervous System. N Engl J Med 1989; 321(7): 442-54.

  33. Valenzuela CF. Alcohol and neurotransmitter interactions. Alcohol Health Res W 1997; 21(2): 144-8.

  34. Cuisinier C. Role of taurine in osmoregulation during endurance exercise. Eur J Appl Physiol 2002; 87(6): 489-95.

  35. Riesselman B, Rosenbaum F, Schneider V. Alcohol and energy drink can combined consumption of both beverages modify automobile driving? Blutalkohol 1996; 33: 4.

  36. Horne JA, Reyner LA. Benefical effects of “energy drink” give sleepy drivers. Amino Acids 2001; 20(1): 83-9.

  37. Reyner LA, Horne JA. Efficacy of a “functional energy drink” in counteracting driver sleepiness. Physiol Behav 2002; 75: 331-5.

  38. Rogers PJ, Martin J, Smith C, Heatherley SV, Smit HJ. Absence of reinforcing, mood and psychomotor performance effects of caffeine in habitual non-consumers of caffeine. Psychopharmacology 2003; 167: 54-62.

  39. Toubro S, Astrup A, Breum L, Quaade F. The acute and chronic effects of ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans. Int J Obes Relat Metab Disord 1993; 17(Suppl. 3): S73-77.

  40. Smith A, Miles C. Effects of lunch on cognitive vigilance tasks. Ergonomics 1986; 29:1251-61.

  41. Smith AP, Kendrick AM, Maben AL, Salmon J. Effects of breakfast and caffeine on performance, mood and cardiovascular functioning. Appetite. 1994; 22: 39-55.

  42. Smith A, Rusted JM, Eaton-Williams P, Savory M, Leathwood P. Effects of caffeine given before and after lunch on sustained attention. Neuropsychobiology 1990; 23:160-3.

  43. Smith A, Maben A, Brockman P. Effects of evening meal and caffeine on cognitive function, mood and cardiovascular functioning. Appetite 1994; 22: 57-65.

  44. Seidl R, Peyrl A, Nicham R, Hauser E. A taurine and caffeinecontaining drink stimulates cognitive performance and wellbeing Part II. Amino Acids 2000; 20: 343-57.

  45. Rosenbaum FA, Riesselmann BE, Schneider VA. Alcohol and energy drink and the combined consumption of both beverages in the automobile performance. Blutalkohol 1998; 45(2): 183-234.

  46. SSA, CONADIC, INPRFM, DGE, INEGI. Encuesta Nacional de Adicciones 2002. México 2003.

  47. Castillo I, Gutiérrez A, Díaz B, Sánchez R, Guisa V. Sistema de Información Epidemiológica del Consumo de Drogas (SIECD) 2002. Centros de Integración Juvenil. En: Observatorio Mexicano de Tabaco, Alcohol y otras drogas 2002. México: CONADIC, SSA; 2003.

  48. Villatoro J, Hernández I, Hernández H, Fleiz C, Blanco J, Medina-Mora ME. Encuesta Nacional sobre el Uso de Drogas entre la Comunidad Escolar a Nivel Nacional y DF 2003. México; 2004.

  49. Guridi RO. TUM III Cruz Roja Mexicana; E-Mergencia/Foros de emergencias hospitalarias/Toxicología http://www.emergencia. com/forum/viewtopic.php?.p=30464.

  50. Hughes JR, Oliveto AH. A systematic survey of caffeine intake in Vermont. Exp Clin Psychopharmacol 1997; 5: 393-8.

  51. Haller CA, Jacob P, Benowitz NL. Enhanced stimulant and metabolic effects of combined ephedrine and caffeine. Clin Pharmacol Ther 2004; 75(4): 259-73.

  52. Ament MA. Taurine supplementation in infants receiving long term parenteral nutrition. J Am Coll Nutr 1986; 5: 129-35.

  53. Souza-Formigoni ML, Boerngen DELR. Combining Alcohol And Red Bull® Reduces The ‘perception’ of Impairment-Alcohol’s Harmful Effects On Motor Coordination, However, Remain Intact. Alcoholism: Clinical & Experimental Research 2006; http://www.alcoholismcer. com.

  54. Warburton DM, Bersellini E, Sweeney E. An evaluation of a caffeinated taurine drink on mood, memory and information processing in healthy volunteers without caffeine abstinence. Psychopharmacology 2001; 158: 322-8.

  55. Lane JD, Phillips-Bute BG. Caffeine deprivation affects vigilance performance and mood. Physiol Behav 1998; 65: 171-5.

  56. Nehlig A, Boyett S. Dose-response study of caffeine effects on cerebral functional activity with a specific focus on dependence. Brain Res 2000; 858: 71-7.

  57. Ellenhorn M. Medical toxicology. Diagnosis and treatment of human poisoning. William and Wilkins; 1997.

  58. Liguori A, Robinson JH. Caffeine antagonism of alcoholinduced driving impairment. Drug Alcohol Dependence 2001; 63(2): 123-9.

  59. Fudin R, Nicastro R. Can caffeine antagonize alcoholinduced performance decrements in humans? Percept Motor Skills 1988; 67(2): 375-91.

  60. Worrall BB, Phillips CD, Henderson KK. Herbal energy drinks, phenylpropanoid compounds, and cerebral vasculopathy. Neurology 2005; 65: 1137-8.

  61. Souza y MM. La educación para la salud mental de la población general y grupos específicos. Memorias. I Reunión sobre Investigación y Enseñanza. México: Instituto Mexicano de Psiquiatría; 1982, p. 142.

  62. Souza y MM. La atención primaria y la educación para la salud mental. Salud Mental 1984; 7(2): 19-23.

  63. Souza y MM. Educación, salud y adicciones. Rev Mex Neuroci 2003; 4(2): 91-3.

  64. Bonci L. “Energy” drinks: Help, Harm Or Hype? Sports Science Exchange 2002; 15(1): 17-18.

  65. http://es.wikipedia.org/wiki/Neurofisiolog%C3%ADa; Fisiología del SNC. 2006.

  66. Soutullo CA, Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, Rhodes SL, Jungvig L, Gagne J. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA 2003; 289(12): 1537-45.

  67. Chen C, Biller J, Willing SJ, Lopez AM. Ischemic stroke after using over the counter products containing ephedra. J Neurol Sci 2004; 217: 55-60.

  68. Scholey AB, Kennedy DO. Cognitive and physiological effects of an “energy drink”: an evaluation of the whole drink and of glucose, caffeine and herbal flavouring fractions. Psychopharmacology 2004; 176: 320-30.

  69. Rojas M. Bebidas energizantes, 2006. http:// www.cedro.org.

  70. Medina-Mora ME, Villatoro J, López E, Berenzon G, Carreño S, Juárez G. Los factores que se relacionan con el inicio, el uso continuado y el abuso de sustancias psicoactivas en adolescentes mexicanos. Gaceta Médica de México 1995; 131(4): 383-93.

  71. Guisa CVM, Díaz Barriga SL, Souza y MM. Terapéutica antiadictiva. Utilidad de sus factores de predicción. Rev Mex Neuroci 2004; 5(6): 581-98.

  72. Franconi F. Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am J Clin Nutr 1995; 61: 1115-19.

  73. Cañas PD. Rol biológico y nutricional de la taurina y sus derivados. Rev Chil Nutr 2002; 29(3): 15-23.

  74. Passmore AP, Kondowe GB, Johnston GD. Renal and cardiovascular effects of caffeine: a dose response study. ClinSci 2004; 72: 749-56.

  75. Machado-Vieira R, Carlos Ivan Viale CI, Kapczinski F. Mania associated with an energy drink: The possible role of caffeine, taurine, and inositol. Can J Psychiatry 2001; 46(5): 454-5.

  76. Bruinvels J, Pepplinkhuizen L, Fekkes D. Derangement of one-carbon metabolism in episodic schizoaffective psychoses. Pharmacopsychiatry 1988; 21: 28-32.

  77. Cottingham EM, Keck PE. Psychosis associated with pseudoephedrine and dextromethorphan. J Am Acad Child Adolesc Psychiatry 1999; 38(12): 1471-2.

  78. Tormey WP, Bruzzi A. Acute psychosis due to the interaction of legal compounds ephedra alkaloids in ‘vigueur fit’ tablets, caffeine in ‘red bull’ and alcohol. Med Sci Law 2001; 41(4): 331-6.

  79. Fekkes D, Pepplinkhuizen L, Verheij R, Bruinvels J. Abnormal plasma levels of serine, methionine, and taurine in transient acute polymorphic psychosis. Psychiatry Res 1994; 51: 11-18.

  80. Smit HJ, Rogers PJ. Effects of “energy” drinks on mood and mental performance: critical methodology. Food Qual Preference 2002; 13: 317-26.

  81. Smith AP. Behavioral effects of caffeine. In: Parliament TH, Ho C-T, Schieberle P (Eds.). Caffeinated beverages: health benefits, physiological effects, and chemistry. New York: Oxford University; 2000, pp 30-45.

  82. Smith A. Effects of caffeine on human behavior. Food Chem Toxicol 2002; 40: 1243-59.

  83. Kaplan HI, Sadock BJ, Grebb JA. Synopsis of psychiatry. 7a. Ed. Edition. Washington: William and Wilkins; l994.

  84. Kilzieh N, Akiskal HD, Tondo L, Rudas N. Rapid-cycling bipolar disorder. An overview of research and clinical. The course of a seasonal bipolar disorder influenced by caffeine. J Affect Disord 1991; 22: 249-51.

  85. Einat H, Belmaker RH. The effects of inositol treatment in animal models of psychiatric disorders. J Affect Disord 2001; 62: 113-21.

  86. Anand A, Verhoeff P, Seneca N, Zoghbi SS, Seibyl JP, Charney DS. Brain SPECT imaging of amphetamineinduced dopamine release in euthymic bipolar disorder patients. Am J Psychiatry 2000; 157: 1108-14.

  87. Souza y MM. Alcoholismo: conceptos básicos. México: Editorial Manual Moderno; 1985.

  88. Guía Técnica. Cap. 8. Intoxicaciones. Definición, Clasificación, Causas y Tratamiento. 2006 Pág. de Internet. Info.a.Med.web. com.mx.

  89. Cofepris, SSA. Bebidas con taurina, cafeína y glucoronolactona. México, D.F., Febrero 3, 2005; contacto_cofepris@salud.gob.mx

  90. Green PJ, Kirby R, Suls J. The effects of caffeine on blood pressure and heart rate: a review. Ann Behav Med 1996; 18: 201-16.

  91. Applegate E. Effective nutritional ergogenic aids. Int J Sport Nutr 1999; 9(2): 229-39.

  92. Ley General de Salud. Nueva Ley publicada en el Diario Oficial de la Federación el 7 de febrero de 1984. Texto vigente. Última reforma publicada. DOF 28-06-2005. México: SSA; 2006.

  93. Azari NP. Effects of glucose on memory processes in young adults. Psychopharmacology 1991; 105: 521-4.

  94. Benton D, Owens DS, Parker PY. Blood glucose influences memory and attention in young adults. Neuropsychologia 1994; 32: 595-607.

  95. Donohoe RT, Benton D. Cognitive functioning is susceptible to the level of blood glucose. Psychopharmacology 1999; 145: 378-85.

  96. Gold PE. Role of glucose in regulating the brain and cognition. Int J Clin Nutr 1995; 61: 987-95.

  97. Hale F, Margen S, Rabak D. Postprandial hypoglycaemia and psychological symptoms. Biol Psychiatry 1982; 17: 125-30.

  98. Kennedy DO, Scholey AB. Glucose administration, heart rate and cognitive performance: effects of increasing mental effort. Psychopharmacology 2000; 149: 63-71.

  99. Korol DL, Gold PE. Glucose, memory, and aging. Am J Clin Nutr 1998; 67(Suppl.): 764-71.

  100. Parsons MW, Gold PE. Glucose enhancement of memory in elderly humans: an inverted-U dose response curve. Neurobiol Aging 1992; 13: 401-4.

  101. Ford CE, Scholey AB, Ayre G, Wesnes K. The effect of glucose administration and the emotional content of words on heart rate and memory. J Psychopharmacol 2002; 16: 241-4.

  102. Foster JK, Lidder PG, Sünram S. Glucose and memory: fractionation of enhancement effects. Psychopharmacology 1998; 137: 259-70.

  103. Sünram-Lea SI, Foster JK, Durlach P. Glucose facilitation of cognitive performance in healthy young adults: examination of the influence of fast-duration, time of day and pre-consumption plasma glucose levels. Psychopharmacology 2001; 157: 46-54.

  104. Wenk GL. An hypothesis of the role of glucose in the mechanism of cognitive enhancers. Psychopharmacology 1989; 99: 431-8.

  105. Gordon RE, Shaked AA, Soleno DF. Taurine protect hamster bronchioles from acute NO2-induced alterations. A histological, ultra-structural and freeze- fracture study. Am J Pathol 1986; 125: 585-600.

  106. Heller-Stilb B. Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice. Faseb J 2002; 16(2): 231-3.

  107. Belli DC. Taurine improves the absorption of a fat meal in patients with cystic fibrosis. Pedriatrics 1987; 80: 517-23.

  108. Weiss SJ. Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J Clin Invest 1982; 70: 598-607.

  109. Aragon CMG, Trudeau LE, Amit Z. Effect of taurine on ethanol-induced changes in openfield locomotor activity. Psychopharmacology 1992; 107(2/3): 337-40.

  110. Dahchour A, Quertemont E, DE Witte P. Taurine increases in the nucleus accumbens microdialysate after ethanol administration to naive and chronically alcholised rats. Brain Res 1996; 735(1): 9-19.

  111. Kerai MD, Waterfield CJ, Kenyon SH, Asker DS, Timbrell JA. Taurine: protective properties against ethanol-induced hepatic steatosis and peroxidation during chronic ethanol consumption in rats. Amino Acids 1998; 15(1-2): 53-76.

  112. Tenenbaum A, Fisman EZ, Motro M. L-arginine: Rediscovery in Progress. Cardiology 1998; 90: 153-9.

  113. Lancet. Editorial L-arginina.1997 (Sept 27); 350: 901.

  114. Lerman A, Burnett JC, Higano ST, McKinley LJ, Holmes DR. Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation 1998; 97(21): 2123-8.

  115. Negase S, Takemura K, Ueda A. A novel nonenzymatic pathway for the generation of nitric oxide by the reaction of hydrogen peroxide and D or L-arginine. Biochem Biophys Res Commun 1997; 233: 150-3.

  116. Moss MC, Scholey AB, Wesnes KA. Oxygen administration selectively enhances cognitive performance in healthy young adults: a placebo-controlled double-blind crossover study. Psychopharmacology 1998; 138: 27-33.

  117. Scholey AB, Moss MC, Neave N, Wesnes KA. Cognitive performance, hyperoxia and heart rate following oxygen administration in healthy young adults. Physiol Behav 1999; 67: 783-9.

  118. Kennedy DO, Scholey AB, Wesnes KA. Differential, dose dependent changes in cognitive performance following acute administration of a Ginkgo biloba/Panax ginseng combination to healthy young volunteers. Nutr Neurosci 2001; 4: 399-412.

  119. Ryu SJ, Chien YY. Ginseng-associated cerebral arteritis. Neurology 1995; 45: 829-30.

  120. Kennedy DO, Scholey AB. Ginseng: potential in the enhancement of cognitive performance and mood (review). Pharmacol Biochem Behav 2003; 75: 687- 700.

  121. Kennedy DO, Scholey AB, Wesnes KA. Differential, dosedependent changes in cognitive performance and mood following acute administration of Ginseng to healthy young volunteers. Nutr Neurosci 2001; 4: 295-310.

  122. Kennedy DO, Scholey AB, Wesnes KA. Modulation of cognition and mood following administration of single doses of Ginkgo biloba, Ginseng and a Ginkgo/Ginseng combination to healthy young adults. Physiol Behav 2002; 75: 1-13.

  123. 123.Kennedy DO, Scholey AB, Wesnes KA. The dose dependent cognitive effects of acute administration of Ginkgo biloba tohealthy young volunteers. Psychopharmacology 2002; 151: 416-23.

  124. Scholey AB, Kennedy DO. Acute, dose-dependent cognitive effects of ginkgo biloba, panax ginseng and their combination in healthy young volunteers: differential interactions with cognitive demand. Hum Psychopharmacol Clin Exp 2002; 17: 35-44.

  125. 125.Wesnes KA, Ward T, McGinty A, Petrini O. The memory enhancing effects of a Ginkgo-biloba/Panax ginseng combination in healthy middle aged volunteers. Psychopharmacology 2000; 152: 353-61.

  126. Kennedy DO, Scholey AB, Tildesley NTJ, Perry EK, Wesnes KA. Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (lemon balm). Pharmacol Biochem Behav 2002; 72: 953-64.

  127. Kennedy DO, Wake G, Savealev S, Tildesley NTJ, Perry EK, Wake G, Wesnes KA, Scholey AB. Modulation of mood and cognitive performance following administration of single doses of Melissa officinalis (lemon balm) with human CNS nicotinic and muscarinic receptor binding properties. Neuropsychopharmacology 2003; 28: 1871-81.

  128. Céspedes VAJ, Naranjo JP, Sebazco PC, Martínez T, Mdel C. Efectos de la tintura de Melissa officinalis l. sobre íleon aislado y en modelo de diarreas. Rev Cubana Med Milit 1996; 25(1): 23-36.

  129. Roig JT. Plantas medicinales aromáticas o venenosas de Cuba. La Habana: Ciencia y Técnica 1971; 561-2.

  130. Ministerio de Salud Pública. Cuba. Plantas medicinales. Fitomed I. La Habana: Editorial Ciencias Médicas; 1991, p. 58.

  131. Leuttig B, Steinmuller C. Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea. J Natl Cancer Inst 1989; 81: 669-75.

  132. See DM, Broumand N, Sahl L, Tilles JG. In vitro effects of echinacea and ginseng on natural killer and antibodydependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients. Immunpharmacol 1997; 35: 229-35.

  133. Melchart D, Linde K. Immunomodulation with Echinaceaa systematic review of controlled clinical trials. Phytomed 1994; 1: 245-54.

  134. Hikino H, Kiso Y, Taguchi H, Ikeya Y. Antihepatotoxic actions of lignoids from Schizandra chinensis fruits. Planta Med 1984; 50: 213-18.

  135. Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the US 1999-2000. Arch Intern Med 2004; 164: 2113-18.

  136. Dawson R, Biasetti M, Messina S, Dominy J. The cytoprotective role of taurine in exercise-induced muscle injury. Amino Acids 2002; 22(4): 309-24.

  137. Dincer S, Ozenirler S, Oz E, Akyol G, Ozogul C. The protective effect of taurine pretreatment on tetrachloride induced hepatic damage. A light and electron microscopic study. Aminoacids 2002; 22: 417-26.

  138. Gaull GF. Taurine in the nutrition of the human infant. Acta Ped Scand 1982; 296(Suppl.): 38-47.

  139. Guizouarn H. Cell volume regulation: The role of taurine loss in maintaining membrane potential and cell pH. J of Physiol 2000; 523: 147-54.

  140. Huxtable RJ. Physiological action of taurine. Physiol Res 1992; 72: 101-3.

  141. Huxtable RJ, Chubb J. b-adrenergic stimulation of taurine transport by the heart. Sci 1977; 198: 409-11.

  142. Ikeda H. Effects of taurine on alcohol withdrawal. Lancet 1977; 2: 509.

  143. Jacobsen JG. Possible physiological functions of taurine in mammalian systems. In: Cavallini D. (Ed.). Rome: Proc 2nd Int Meeting on Low Molecular Weight Sulfur- Containing Natural Products; 1979, p. 163-72.

  144. Mantovani J, De Vivio DC. Effects of taurine on seizures and growth hormone release in epileptic patients. Arch Neurol 1979; 36: 672-4.

  145. Matsuzaki YL. Decreased taurine concentration in skeletal muscles after exercise for various durations. Med Sci Sports Exerc 2002; 34(5): 793-7.

  146. Moran J, Pasantes-Morales H. Effect of -tocopherol and taurine on membrane fluidity in retinal rod outer segments.a Exp Eye Res 1987; 45: 769-76.

  147. Mrsny R, Meizel S. Inhibition of hamster sperm Na-K+ ATPase activity by taurine and hypotaurine. Life Sci 1984; 36: 272-6.

  148. Raghon C. Probable mode of taurine action 1982; 20: 481-3.




2020     |     www.medigraphic.com